Cost effectiveness is presented as costs and mortality reductions following initial 16 weeks of therapy; and for the entire period between ART services initiation at each site and July 1, 2008. Means
Objective We estimated the average annual cost per patient of ART per facility (unit cost) in Nigeria, described the variation in costs across facilities, and identified factors associated with this v
Unit costs (in 2012 US$) of the different components of ART services for patients initiating treatment with CD4 count <200 cells/mm3 in Dar es Salaam, Tanzania.
